^{* All development phases not applicable for 505(b)2 regulatory filings.}

^{** See warnings and full prescribing information. Marketed in the U.S. by Meda Pharmaceuticals.}

^{*** Licensed worldwide to Endo Health Solutions.}

Dr. Mark A. Sirgo will be presenting at the

Bank of America Merrill Lynch 2013 Health Care Conference

Tuesday, May 14 2013 at 5:00 p.m. Pacific Time (8:00 p.m. Eastern Time)

Click Here for the Webcast

_______________________________

BioDelivery Sciences International

R&D DAY

Thursday, March 7, 2013 at 12:00 Noon, ET

Click Here for Live Webcast of Presentation

 Treatment of Pain and Opioid Dependence with Buprenorphine

   Speakers

 Joseph Pergolizzi, MD

Pain Medicine Specialist

Assistant Professor of Medicine

Johns Hopkins School of Medicine

 Gregory Sullivan, MD

Addiction Medicine Specialist

Parkway Medical Center

Birmingham, Alabama

 Genie L Bailey, MD

Psychiatrist/Addiction Medicine Specialist

Medical Director, Stanley St. Treatment and Resources (SSTAR)

 Faculty, Brown University

________________________________________